Europe — EMA
Evoltra (Clofarabine)
Evoltra is a medication containing clofarabine, used for specific medical conditions. This intravenous treatment is manufactured by Sanofi B.V. and is available
Request sourcing
What is Clofarabine?
Evoltra is a medication containing clofarabine, used for specific medical conditions. This intravenous treatment is manufactured by Sanofi B.V. and is available in the EU.
What is Clofarabine used for?
Evoltra is primarily used in the treatment of certain types of cancer. It works by interfering with the growth of cancer cells. Patients often wonder, 'What is Evoltra used for?' and the answer lies in its application for targeted cancer therapies.
What are the side effects of Clofarabine?
Common effects of Evoltra may include fatigue, nausea, and low blood cell counts. These effects can vary from person to person and are typically managed under medical supervision.
What precautions apply to Clofarabine?
Evoltra should be handled with care, as it is intended for intravenous use only. It is important to follow all safety guidelines provided by healthcare professionals to ensure proper administration.
What does Clofarabine interact with?
Evoltra may interact with other medications, including those that affect the immune system or blood cell production. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.
